Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamivudine extension therapy in chronic hepatitis B
NCT02337127Phase 4Unknown
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Jun 2011
- Primary completion
- May 2015
- Countries
- 1
01
Overview
Phase 4, open-label trial of lamivudine in Chronic Hepatitis B (CHB) (2 arms), sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Primary endpoint: Rate of HBV DNA recurrence at 12 months. Status: unknown.
02
Drugs
lamivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02337127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02337127.